Mitera Biosciences
Bellevue, US · Founded 2020 · Delaware corporation
Founders & leadership
KC
Kevin ChowNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 2 rounds · 2024–2026
▶$1.1MraisedMay 2026 · 2 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ChowExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $1.1M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2025 · 6 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ChowExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $1.7M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Mitera Biosciences raised?
- Mitera Biosciences has disclosed $2.8M raised across 2 rounds.
- Where is Mitera Biosciences headquartered?
- Mitera Biosciences is headquartered in Bellevue, US.